IPOS trademark

Alnylam Pharmaceuticals, Inc design mark 40201815072U

RegisteredIPOSFigurative markClass 5

"Design mark 40201815072U" is a figurative mark owned by Alnylam Pharmaceuticals, Inc., filed at the IPOS on August 1, 2018. It is registered and covers class 5 (Pharmaceuticals).

View Alnylam Pharmaceuticals, Inc. portfolioGet this data via the API
Official IPOS record
Alnylam Pharmaceuticals, Inc design mark 40201815072U trademark as filed
As filed with the IPOS
Status
Registered
Since August 1, 2018
Filed
August 1, 2018
Registered
March 12, 2019
Expires
August 1, 2028
Application no.
40201815072U
Registration no.
40201815072U
Office
IPOS
Intellectual Property Office of Singapore
Mark type
Figurative mark
1 class
Ownership

Who owns Alnylam Pharmaceuticals, Inc design mark 40201815072U

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Alnylam Pharmaceuticals, Inc.

ALNY · United States

69 trademarks in the portfolioView company

Representative

Allen & Gledhill LLP

Allen & Gledhill LLP

Goods and services

What the mark covers

The products and services Alnylam Pharmaceuticals, Inc design mark 40201815072U is filed for, grouped by Nice class.

  • Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection; Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection; pharmaceutical preparations, namely, RNA therapeutics; pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes

History

What has happened so far

Steps recorded by the IPOS, newest first.

  1. Registration procedure completed
  2. Application filed
FAQ

About Alnylam Pharmaceuticals, Inc design mark 40201815072U

Who owns the trademark "Design mark 40201815072U"?

The IPOS trademark "Design mark 40201815072U" (application 40201815072U) is owned by Alnylam Pharmaceuticals, Inc.

What is the status of "Design mark 40201815072U"?

Its status at the IPOS is: registered.

When was "Design mark 40201815072U" registered?

It was registered on March 12, 2019 and is due to expire on August 1, 2028.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Alnylam Pharmaceuticals, Inc design mark 40201815072U and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019df66c-9131-7788-ab8b-f1110bacfffa
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019df66c-9131-7788-ab8b-f1110bacfffa",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "SG",
  "application_number": "40201815072U",
  "filing_date": "2018-08-01",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Alnylam Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb709-7d9a-70dc-b19d-2c56e8a223b5"
    }
  ]
}